View in EDS HTML Full Text PDF Full Text

Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.

Saved in:
Bibliographic Details
Title: Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.
Authors: Wang, Wei1 (AUTHOR), Peng, Siming1 (AUTHOR), Gao, Sihao1 (AUTHOR), Quan, Meiying1 (AUTHOR), Gou, Lijuan1 (AUTHOR), Wang, Changyan1 (AUTHOR), Sun, Zhixing1 (AUTHOR), Li, Zhuo1 (AUTHOR), Lian, Dongmei1 (AUTHOR), Song, Hongmei1 (AUTHOR) songhm1021@126.com
Source: Pediatric Rheumatology. 10/12/2023, Vol. 21 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15460096
DOI:10.1186/s12969-023-00899-4